Merck & Co Inc (TSX:MRK)
C$ 28.29 -0.030 (-0.11%) Market Cap: 441.77 Bil Enterprise Value: 503.48 Bil PE Ratio: 35.49 PB Ratio: 6.78 GF Score: 64/100

Merck & Co Inc at Citi Global Healthcare Conference Transcript

Dec 03, 2025 / 06:00PM GMT
Release Date Price: C$23.18 (+0.91%)
Geoffrey Meacham;Douala Branch;Analyst
Citibank Cameroon SA

()-

Second day of the Citi Global Healthcare Conference. So my name is Geoff Meacham. I'm the senior biopharma analyst of Mary-Kate Davis with me as well from my team here on stage. So we're thrilled to have Merck in this session, and we have Eliav Barr, who was SVP Head of Global Clinical Development and CMO; and then Chirfi Guindo, Chief Marketing Officer. So Eliav, good to see you guys.

Eliav Barr
Merck & Co Inc - SVP Head of Global Clinical Development and CMO

So here as well. Thank you for having us.

Questions & Answers

Geoffrey Meacham;Douala Branch;Analyst
Citibank Cameroon SA

()-

Thanks for the time. So maybe we'll start with the -- first, with the Cidara deal, right? So maybe just give us some kind of context for the thought process that went into this. I mean I'm assuming it's more than just kind of economics and to try to manage the LOE. This is a real growth

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot